Literature DB >> 1690427

Suppression of tumor-forming ability and related traits in MCF-7 human breast cancer cells by fusion with immortal mammary epithelial cells.

D A Zajchowski1, V Band, D K Trask, D Kling, J L Connolly, R Sager.   

Abstract

Somatic cell hybrids between MCF-7 human breast cancer cells and normal immortalized human mammary epithelial cells have been obtained by polyethylene glycol-mediated cell fusion. The hybrid cells are suppressed in their ability to form tumors in nude mice, as well as in traits specific to the tumorigenic MCF-7 parent: growth factor independence, tumor necrosis factor sensitivity, and pS2 gene expression. In addition, they display other characteristics of the "normal" parent, including increased expression relative to the MCF-7 cells of the genes for the extracellular matrix component fibronectin, the intermediate filament keratin 5, and the angiogenesis inhibitor thrombospondin. The levels of keratins 8 and 18 also resemble those of the nontumorigenic parent. These results provide evidence for the existence of tumor suppressor gene products in immortal mammary epithelial cells. We propose a characteristic "suppressed" tumor cell phenotype, which encompasses altered cytoarchitecture, angiogenesis capabilities, and growth factor requirements.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1690427      PMCID: PMC53677          DOI: 10.1073/pnas.87.6.2314

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  The use of restriction fragment polymorphisms to identify the cell line MCF-7.

Authors:  K A Graham; J M Trent; C K Osborne; C M McGrath; M D Minden; R N Buick
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

2.  Characterization of the estrogen-induced pS2 protein secreted by the human breast cancer cell line MCF-7.

Authors:  A M Nunez; S Jakowlev; J P Briand; M Gaire; A Krust; M C Rio; P Chambon
Journal:  Endocrinology       Date:  1987-11       Impact factor: 4.736

3.  Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene.

Authors:  M R Stampfer; J C Bartley
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

Review 4.  Genetic suppression of tumor formation.

Authors:  R Sager
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

5.  Regulation of thrombospondin secretion by cells in culture.

Authors:  S M Mumby; D Abbott-Brown; G J Raugi; P Bornstein
Journal:  J Cell Physiol       Date:  1984-09       Impact factor: 6.384

6.  Isolation and regional localization of DNA segments revealing polymorphic loci from human chromosome 13.

Authors:  W Cavenee; R Leach; T Mohandas; P Pearson; R White
Journal:  Am J Hum Genet       Date:  1984-01       Impact factor: 11.025

7.  Keratins as markers that distinguish normal and tumor-derived mammary epithelial cells.

Authors:  D K Trask; V Band; D A Zajchowski; P Yaswen; T Suh; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

8.  Biological effects of recombinant human tumor necrosis factor and its novel muteins on tumor and normal cell lines.

Authors:  A A Creasey; L V Doyle; M T Reynolds; T Jung; L S Lin; C R Vitt
Journal:  Cancer Res       Date:  1987-01-01       Impact factor: 12.701

9.  Induction of tumor necrosis factor expression and resistance in a human breast tumor cell line.

Authors:  D Spriggs; K Imamura; C Rodriguez; J Horiguchi; D W Kufe
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

10.  Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.

Authors:  B J Sugarman; B B Aggarwal; P E Hass; I S Figari; M A Palladino; H M Shepard
Journal:  Science       Date:  1985-11-22       Impact factor: 47.728

View more
  22 in total

1.  A novel in vitro model of tumor angiogenesis.

Authors:  D Kozien; M Gerol; B Hendey; A RayChaudhury
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-10       Impact factor: 2.416

2.  Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells.

Authors:  O W Petersen; L Rønnov-Jessen; A R Howlett; M J Bissell
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

Review 3.  Endothelial cells and angiogenic growth factors in cancer growth and metastasis. Introduction.

Authors:  J Folkman
Journal:  Cancer Metastasis Rev       Date:  1990-11       Impact factor: 9.264

4.  Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro.

Authors:  M L Iruela-Arispe; P Bornstein; H Sage
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

Review 5.  Intratumor microvessel density as a prognostic factor in cancer.

Authors:  N Weidner
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

6.  Measurement of gap junctional communication by fluorescence activated cell sorting.

Authors:  D T Kiang; R Kollander; H H Lin; S LaVilla; M M Atkinson
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-11       Impact factor: 2.416

7.  Diverse gene sequences are overexpressed in werner syndrome fibroblasts undergoing premature replicative senescence.

Authors:  S Murano; R Thweatt; R J Shmookler Reis; R A Jones; E J Moerman; S Goldstein
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

8.  Classification of breast cancer cells on the basis of a functional assay for estrogen receptor.

Authors:  D K Biswas; L Averboukh; S Sheng; K Martin; D S Ewaniuk; T F Jawde; F Wang; A B Pardee
Journal:  Mol Med       Date:  1998-07       Impact factor: 6.354

9.  Characterization of the estrogen receptor transfected MCF10A breast cell line 139B6.

Authors:  M J Pilat; J K Christman; S C Brooks
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

10.  Expression of the type-1 repeats of thrombospondin-1 inhibits tumor growth through activation of transforming growth factor-beta.

Authors:  Karen O Yee; Michael Streit; Thomas Hawighorst; Michael Detmar; Jack Lawler
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.